Position
Executive Vice President
Company
Cognito Therapeutics
CambridgeManufacturingBiotechnologyHealthcareHealth CareMedicalTherapeuticsDescription
Cognito Therapeutics has announced the appointment of Thomas Fagan as Executive Vice President of its Alzheimer's Portfolio. He will lead the company's Alzheimer's strategy and advance its commercialization efforts.
Quick answer
Cognito Therapeutics Appoints Thomas Fagan as Executive Vice President (March 11, 2026). Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Executive Vice President at Cognito Therapeutics?
- Cognito Therapeutics named Thomas Fagan Executive Vice President, announced March 11, 2026.
- What did Cognito Therapeutics announce on March 11, 2026?
- Cognito Therapeutics has announced the appointment of Thomas Fagan as Executive Vice President of its Alzheimer's Portfolio. He will lead the company's Alzheimer's strategy and advance its commercialization efforts.
- What does Cognito Therapeutics do?
- Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance.
- Where is Cognito Therapeutics based?
- Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Aquestive Therapeutics, Inc. (March 20, 2026), Bristol Myers Squibb (February 9, 2026), MBX Biosciences, Inc. (March 10, 2026) and AEON Biopharma (March 9, 2026) also announced leadership changes within 45 days of Cognito Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Medical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs. (February 9, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- AEON Biopharma Appoints John Bencich as Chief Financial Officer (March 9, 2026)
- Certus Critical Care Appoints JD Simpson as Chief Executive Officer (March 9, 2026)
- BiomX Appoints Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer (March 9, 2026)
Who to call at Cognito Therapeutics, and when
A new leader at Cognito Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cognito Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cognito Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cognito Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cognito Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.